"North Idaho Urology helps patients in northern Idaho feel better. In our Coeur d'Alene offfice, we treat a full range of urologic conditions such as: Prostate Cancer (from diagnosis to advanced-stage treatment) Female Urinary Incontinence Kidney Stones Erectile Dysfunction Overactive Bladder (OAB) Urinary Retention Enlarged Prostate (BPH) Low Testosterone (Low T) Pelvic Prolapse Hematuria (Blood in urine) Kidney Cancer Bladder Cancer Urinary Tract Infection And perform urology procedures like: Vasectomy Vasectomy Reversal Prostate exams / PSA tests Prostate Cancer Robotic Surgery (prostatectomy) Lithotripsy Rezum for BPH Interstim for OAB Botox for OAB Circumcision Mona Lisa Touch"

During the past decade, North Idaho Urology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Idaho Urology" #1 sponsor was "Allergan" with 2 trials, followed by "Bavarian Nordic" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored and "Active Biotech AB" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Idaho Urology" #1 collaborator was "Allergan" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "TARIS Biomedical, Inc." with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "North Idaho Urology" are "Prostate Cancer" (7 trials), "Bladder Cancer" (3 trials), "Prostate Cancer Metastatic" (2 trials), "Benign Prostatic Hypertrophy" (1 trials) and "Enteric Hyperoxaluria" (1 trials). Many other conditions were trialed in "North Idaho Urology" in a lesser frequency.

Most popular intervention types in "North Idaho Urology" are "Drug" (16 trials), "Procedure" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apaziquone" (2 trials), "ABR-215050, tasquinimod" (1 trials), "ALLN-177" (1 trials) and "Cetrorelix Pamoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Idaho Urology" are 10 trials for "Male" genders, 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "North Idaho Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in North Idaho Urology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in North Idaho Urology, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".